These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3191482)

  • 1. Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.
    Stacker SA; Thompson CH; Sacks NP; Tjandra J; Lowe MG; Bishop J; McKenzie IF
    Cancer Res; 1988 Dec; 48(24 Pt 1):7060-6. PubMed ID: 3191482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancer.
    Stacker SA; Thompson CH; Lowe MG; Sacks NP; Golder J; Carmen H; McKenzie IF
    Dev Biol Stand; 1987; 67():91-6. PubMed ID: 3609486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients.
    Linsley PS; Ochs V; Laska S; Horn D; Ring DB; Frankel AE; Brown JP
    Cancer Res; 1986 Oct; 46(10):5444-50. PubMed ID: 2428478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAM-6 antigen, a new serum marker for breast cancer monitoring.
    Hilkens J; Kroezen V; Bonfrer JM; De Jong-Bakker M; Bruning PF
    Cancer Res; 1986 May; 46(5):2582-7. PubMed ID: 3697998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer.
    Iacobelli S; Arnò E; D'Orazio A; Coletti G
    Cancer Res; 1986 Jun; 46(6):3005-10. PubMed ID: 3516389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
    Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22.
    Papsidero LD; Nemoto T; Croghan GA; Chu TM
    Cancer Res; 1984 Oct; 44(10):4653-7. PubMed ID: 6088042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
    Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
    Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [MSA--a new sensitive tumor marker in breast carcinoma].
    Zahm DM; Greinke C; Nöschel H
    Zentralbl Gynakol; 1996; 118(12):659-64. PubMed ID: 9082702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.
    Stacker SA; Tjandra JJ; Xing PX; Walker ID; Thompson CH; McKenzie IF
    Br J Cancer; 1989 Apr; 59(4):544-53. PubMed ID: 2469454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of mammary serum antigen assay in the management of breast cancer: a preliminary report.
    Tjandra JJ; Russell IS; Collins JP; Stacker SA; McKenzie IF
    Br J Surg; 1988 Aug; 75(8):811-7. PubMed ID: 3048535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of human monoclonal antibody to detect serum antigen in patients with breast cancer.
    Strelkauskas AJ; Aldenderfer PH; Warner GA
    Anticancer Res; 1989; 9(6):1863-8. PubMed ID: 2627133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating adenocarcinoma-associated antigen in the sera of cancer patients with a monoclonal antibody.
    Hinoda Y; Imai K; Endo T; Yamashita T; Yachi A
    Jpn J Cancer Res; 1985 Dec; 76(12):1203-11. PubMed ID: 2419298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
    Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody PR92 with restricted specificity for tumor-associated antigen of prostate and breast carcinoma.
    Kim YD; Robinson DY; Tomita JT
    Cancer Res; 1988 Aug; 48(16):4543-8. PubMed ID: 3396007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies.
    Salinas FA; Wee KH; Ceriani RL
    Cancer Res; 1987 Feb; 47(3):907-13. PubMed ID: 3802085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.
    Stacker SA; Sacks NP; Golder J; Tjandra JJ; Thompson CH; Smithyman A; McKenzie IF
    Br J Cancer; 1988 Mar; 57(3):298-303. PubMed ID: 3355770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of a tumor-associated antigen CA 15-3 in the sera of patients with breast cancer].
    Ogawa T; Izuo M; Morita H; Ishida T; Iino Y; Hoshino K; Yokoe T; Suzuki H; Murata S; Matsuzaki S
    Gan No Rinsho; 1986 Jan; 32(1):27-32. PubMed ID: 3456454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.